Cybersecurity, architecture, and assessments that build security into applications, infrastructure, and operations from the start — not added after the product is finished.

Access that reflects who should actually see what, backups that have been tested to restore, and a system built to be defensible before anything goes wrong — not after.

Secure

Access inventory

Role rationalisation

Logging assessment

Break-glass design

Data at rest and in transit

Retention and disposal

Third-party access

Breach readiness

Remediation plan

Retest

Clinical Data Access Audit and Hardening

The most common real finding in a facility of this kind is that a long-serving administrator has accumulated access far beyond their role, often because they were helpful during a crisis years ago. Removing it is a political act, not a technical one. Afivox reports findings to the engaging authority confidentially and does not adjudicate internal consequences — and the engagement letter should say so before work starts.

An access review names people, and some of those people will be senior.

The system can generate it; only the facility can commit to reading it. A remediation plan that depends on a review nobody performs should be marked as unmitigated rather than closed.

Break-glass access only works if someone reviews the report.

[FILL: confirm the facility's specific obligations — NDPA, any HMO contractual requirements, and professional body guidance — before scoping. Afivox assesses against the facility's stated obligations and does not offer legal advice on what they are.]

Regulatory note

Register review

Segregation of duties

Reconciliation design

Discrepancy workflow

Storage and physical control

Audit trail

Inspection readiness

Controlled Substance Audit and Compliance

This must be established in the engagement letter before work begins: Afivox reports findings confidentially to the engaging authority — normally the superintendent pharmacist or the facility head — and the client takes its own legal and professional advice on what follows. A consultancy that positions itself as able to help a client manage a controlled-substance discrepancy quietly is offering something it should not.

A discrepancy found during this engagement may be a regulatory matter and may implicate a named member of staff, and Afivox is not in a position to advise on either.

A procedure that requires a weekly count from staff who do not have the time will lapse within a month, and a lapsed procedure is worse in an inspection than an honest ad-hoc one. The cadence must be set against real staffing.

Reconciliation only works if it actually happens at the designed cadence.

[FILL: confirm applicable NDLEA, PCN and NAFDAC requirements for controlled substance record-keeping, storage and inspection with the client's superintendent pharmacist before scoping. Publish no specific regulatory claims on the website until verified.]

Scope and authorisation document

Findings register

Ranked remediation plan

Technical report

Executive summary

Retest report

Security Assessment and Remediation Plan

This has to be said plainly on the page and in the first meeting, because the fear is what stops organisations commissioning the work. An assessment that finds nothing means the scope was too narrow. The report should open by naming that expectation rather than burying it.

Nobody has a clean first assessment, and the buyer's real fear is not the attacker, it is how they will look.

The honest positions are a maintenance window, a staging environment that genuinely mirrors production, or a reduced-intensity test with the limitation stated in the report. Pretending there is a risk-free option is how assessments take down a business's order system on a Friday.

Testing production systems carries a real risk of disruption.

Identity

Network

Secrets

Logging

Backup and restore

Patching

Baseline

Deliverables

Cloud and Application Hardening

Removing a shared login that three staff quietly depend on stops their day. Closing an exposed port disables an integration nobody documented. Every change needs a window, a rollback, and a named person who knows what changed — and the organisation has to accept some disruption. A hardening engagement done without change windows to avoid disruption will be reversed within a week by whoever it inconvenienced.

Hardening breaks things, and the breakage lands on people who did not ask for the work.

It is a policy decision that the organisation must make and enforce. Afivox can implement it; only the organisation can require it.

Multi-factor enforcement is where these engagements stall, particularly with senior staff and particularly where people share devices.

Application inventory

Ownership

Review campaigns

Access review

Exceptions

Remediation

Evidence

Reporting

Enterprise Security & Access Review Hub

An owner who rubber-stamps every review without actually looking defeats the entire exercise, and the system can make the review fast but cannot make someone look. The honest framing during scoping is that this depends on management actually holding owners accountable for their reviews, which is a process commitment, not a software feature.

This system creates accountability; it doesn't create the will to act on what it finds.

This records the decision to revoke access; it doesn't have the authority or the integration depth to revoke it directly across every application in a large organisation's estate. Where that gap matters, the recommendation is a phased integration starting with the highest-risk systems, not a promise of enterprise-wide automated revocation from day one.

Remediation depends on systems this tool doesn't control.

Secure work

Secure projects

Clinical Data Access Audit and Hardening

Controlled Substance Audit and Compliance

Security Assessment and Remediation Plan

Cloud and Application Hardening

Enterprise Security & Access Review Hub